BRPI0910637A2 - Método para o tratamento de um indivíduo castrado do sexo masculino que padece de fogalhos - Google Patents

Método para o tratamento de um indivíduo castrado do sexo masculino que padece de fogalhos

Info

Publication number
BRPI0910637A2
BRPI0910637A2 BRPI0910637-5A BRPI0910637A BRPI0910637A2 BR PI0910637 A2 BRPI0910637 A2 BR PI0910637A2 BR PI0910637 A BRPI0910637 A BR PI0910637A BR PI0910637 A2 BRPI0910637 A2 BR PI0910637A2
Authority
BR
Brazil
Prior art keywords
shingles
treatment
person suffering
castrated male
male person
Prior art date
Application number
BRPI0910637-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Louis Monti
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of BRPI0910637A2 publication Critical patent/BRPI0910637A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
BRPI0910637-5A 2008-04-09 2009-04-09 Método para o tratamento de um indivíduo castrado do sexo masculino que padece de fogalhos BRPI0910637A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12362208P 2008-04-09 2008-04-09
PCT/US2009/040102 WO2009126825A1 (en) 2008-04-09 2009-04-09 Steroid treatment for hot flashes

Publications (1)

Publication Number Publication Date
BRPI0910637A2 true BRPI0910637A2 (pt) 2015-07-28

Family

ID=41162250

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910637-5A BRPI0910637A2 (pt) 2008-04-09 2009-04-09 Método para o tratamento de um indivíduo castrado do sexo masculino que padece de fogalhos

Country Status (10)

Country Link
US (2) US20090258040A1 (cg-RX-API-DMAC7.html)
EP (1) EP2278880B1 (cg-RX-API-DMAC7.html)
JP (1) JP5524177B2 (cg-RX-API-DMAC7.html)
KR (1) KR101602802B1 (cg-RX-API-DMAC7.html)
CN (1) CN102056484B (cg-RX-API-DMAC7.html)
AU (1) AU2009234159B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0910637A2 (cg-RX-API-DMAC7.html)
DK (1) DK2278880T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010011063A (cg-RX-API-DMAC7.html)
WO (1) WO2009126825A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3068590A1 (en) 2017-07-06 2019-01-10 Dignity Health Novel treatment for hot flushes
KR20210151836A (ko) 2019-04-15 2021-12-14 페린 파마슈티칼즈, 인코포레이티드 편두통의 치료
WO2024254005A1 (en) * 2023-06-04 2024-12-12 Vistagen Therapeutics, Inc. 1,3,5(10),16-estratetraen-3-yl acetate for use in improving psychomotor or cognitive performance
US20250312356A1 (en) * 2024-04-08 2025-10-09 Vistagen Therapeutics, Inc. Treatment of dysmenorrhea

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (de) * 1961-04-29 1963-12-12 Schering Ag Verfahren zur Herstellung von 6-Chlor-1, 2ª‡-methylen-í¸-17ª‡-hydroxyprogesteronestern
US6140316A (en) * 1991-01-07 2000-10-31 Pherin Corporation Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
US5303703A (en) * 1991-10-03 1994-04-19 Pherin Corporation Combined neuroepithelial sample delivery electrode device and methods of using same
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6057439A (en) 1994-08-04 2000-05-02 Pherin Corporation Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US6117860A (en) * 1994-08-04 2000-09-12 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
US6331534B1 (en) * 1994-08-04 2001-12-18 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate pain
DE69736833T2 (de) * 1996-07-23 2007-05-24 Pherin Pharmaceuticals, Inc., Menlo Park Steroide als neurochemische stimulatoren des nasenraumes zur linderung der prämenstrualen symptome
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
US20030045514A1 (en) * 2001-05-03 2003-03-06 Louis Monti 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
RS20080200A (sr) * 2005-11-14 2009-07-15 Rinat Neuroscience Corp., Antagonistička antitela usmerena protiv kalcitonina, peptida povezanog sa genom, i postupak njihovog korišćenja
US20080293683A1 (en) 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy

Also Published As

Publication number Publication date
CN102056484B (zh) 2014-10-29
EP2278880A4 (en) 2011-08-10
KR20110014147A (ko) 2011-02-10
HK1157142A1 (en) 2012-06-29
WO2009126825A1 (en) 2009-10-15
US8431559B2 (en) 2013-04-30
DK2278880T3 (da) 2012-11-12
JP5524177B2 (ja) 2014-06-18
JP2011518136A (ja) 2011-06-23
US20090258040A1 (en) 2009-10-15
EP2278880A1 (en) 2011-02-02
KR101602802B1 (ko) 2016-03-11
US20120108558A1 (en) 2012-05-03
EP2278880B1 (en) 2012-10-10
AU2009234159A1 (en) 2009-10-15
MX2010011063A (es) 2010-11-22
AU2009234159B2 (en) 2013-12-19
CN102056484A (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
BRPI0916184A8 (pt) método para a formação de um equipamento de iluminação e equipamento de iluminação
ZA201200263B (en) Compounds and methods for treating influenza
BRPI0904960A2 (pt) Método para tratar um mamífero que sofre de dor
BRPI0816784A2 (pt) Fatores neuro-endócrinos para o tratamento de doenças degenerativas
BR112012003365A2 (pt) método e dispositivo para a fabricação de objetos de titânio.
BRPI1010937A2 (pt) composto, uso de um composto, e, método para tratar câncer
EP2251064A4 (en) HYGIENE MASK FOR THE PROTECTION OF OTHERS
GB2473406B (en) Showerhead for emergency fixture
DK2408807T3 (da) Fremgangsmåde til terapeutisk anvendelse
BR112012000434A2 (pt) procedimento para a fabricação de piscinas naturais.
DK2452189T3 (da) Fremgangsmåde til identifikation af forbindelser til behandling af cancer
BRPI0911077A2 (pt) método para tratamento de biomassa
GB0823480D0 (en) Devices for the treatment of fluids
BR112012009819A2 (pt) cabide para um dispositivo de tratamento de lavatório
BRPI0811844A2 (pt) Composto, e, método para tratar um paciente
EP2242989A4 (en) DEVICE FOR ENHANCED EXPLOSION METHOD
BRPI0909144A2 (pt) Processo para o tratamento de água de descarga e instalação de tratamento de água de descarga
ZA201101117B (en) Method and system for enhancing the safety of a region
DK2202700T3 (da) System til kontrol af en person
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
ZA201008192B (en) A phytosystem for treatment of sewage
DK2149372T3 (da) Anvendelse af opioider af metadongruppen til behandling af patienter med resistent cancer
BRPI1008016A2 (pt) método para o tratamento de águas residuais
DK2285416T3 (da) Konjugat til behandlingen af mesotheliom
BRPI0910637A2 (pt) Método para o tratamento de um indivíduo castrado do sexo masculino que padece de fogalhos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]